Echolight
Echolight is an Italian medical device company that develops and sells REMS, a patented radiation-free ultrasound technology for bone densitometry at the lumbar vertebrae and femoral neck. It serves hospitals, pharmacies, home care providers, and wellness centers globally through 40+ distributors and direct US sales.
- Company typePrivate
- Founded2010
- HeadquartersLecce, Italy
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Echolight does
Echolight S.p.A. is an Italian medical device company founded in 2010 as a spin-off of the Italian National Research Council (CNR), headquartered in Lecce with US operations through wholly-owned Echolight Medical Corp. (Houston, TX and Kenmore, WA). The company develops and commercializes REMS (Radiofrequency Echographic Multi Spectrometry), a proprietary, patented ultrasound-based bone densitometry technology that measures bone mineral density and microarchitectural quality at the lumbar vertebrae and femoral neck without ionizing radiation. Its core product line — EchoS and its variants (EchoS Plus, EchoStation, EchoHybrid, EchoHybrid Plus) — is complemented by the EchoStudio software suite (Bone Density, Body Composition, Fragility Score, Fracture Risk, Skeletal, Gynecology) and dedicated ultrasound probes.
The technology is clinically validated across 10,000+ subjects in multicenter international studies and supported by a proprietary 15,000+ subject reference database. Regulatory assets include FDA 510(k) clearance (2017), CE mark, ISO 13485:2016 and ISO 9001:2015 certifications, Italian ISS guideline inclusion (2020), Poland 2026 guideline inclusion, and a US CPT code assignment (2024). Differentiating features include automatic artifact rejection (addressing DXA overestimation in osteoarthritic patients), radiation-free operation enabling use in pregnant women, children, and frequent monitoring, and portable device form factors suitable for pharmacy, home care, and bedside use.
Echolight monetizes primarily through one-time hardware sales of bone densitometry devices and separately licensed EchoStudio software modules, distributed globally through 40+ resellers and a direct enterprise sales force in North America. Customers include hospitals, specialized osteoporosis and bone health clinics, retail and clinical pharmacies (point-of-care screening), wellness and anti-aging centers, home care providers, and research institutions (including NASA for bedrest and spaceflight bone-loss studies). The company is led by founder and CEO Sergio Casciaro, with Mike Yuja serving as Chief Commercial Officer and North America General Manager since January 2025.
Echolight firmographics
Firmographics- Name
- Echolight
- Legal name
- Echolight S.p.A.
- Website
- https://echolightmedical.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Echolight is an Italian medical device company that develops and sells REMS, a patented radiation-free ultrasound technology for bone densitometry at the lumbar vertebrae and femoral neck. It serves hospitals, pharmacies, home care providers, and wellness centers globally through 40+ distributors and direct US sales.
- Ownership category
- akta.pro rank
Echolight industry classification
Industry- Product category
- Bone Densitometry Equipment
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Ultrasound & Echography Systems (HLAHABAD)
Keywords
Where Echolight is headquartered
LocationHeadquarters
- HQ city
- Lecce
- HQ country
- Italy
- HQ region
- Europe
Offices3 records
Markets served
Echolight business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Bone Densitometry Hardware Sales: Sale of EchoS, EchoStation, EchoHybrid, and EchoHybrid Plus device configurations including main ultrasound unit, probes, and accessories. Devices are sold directly and through distributor network globally.
- Software Licenses: EchoStudio software applications sold separately including Bone Density, Body Composition, Fragility Score, Fracture Risk, Skeletal, and Gynecology modules.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
Echolight product offering
Product offeringCore offering
Echolight manufactures and sells the EchoS family of ultrasound bone densitometers that use proprietary REMS (Radiofrequency Echographic Multi Spectrometry) technology to assess bone mineral density and microarchitectural quality at the lumbar vertebrae and proximal femur without ionizing radiation. The offering includes multiple hardware configurations (portable and workstation variants) for hospitals, clinics, pharmacies, home care, and wellness settings, paired with a suite of EchoStudio software modules covering bone density, body composition, fragility score, fracture risk, skeletal, and gynecological assessments. Customers include medical facilities, retail pharmacies, wellness centers, and research organizations such as NASA.
Product overview
Echolight offers a comprehensive bone health assessment ecosystem centered on REMS (Radiofrequency Echographic Multi Spectrometry) technology. The core product is EchoS - a radiation-free bone densitometer available in multiple configurations (EchoS, EchoS Plus, EchoStation, EchoHybrid, EchoHybrid Plus) for different clinical settings. Software modules (EchoStudio Bone Density, Body Composition, Fragility Score, Fracture Risk, Skeletal, Gynecology) extend functionality. Hardware accessories include specialized ultrasound probes. The system replaces traditional DXA with portable ultrasound technology that provides BMD measurements, T/Z-scores, and proprietary Fragility Scores for fracture risk prediction without ionizing radiation.
Differentiator
Problem solved
Functional benefit
Brands
- EchoS: The only ultrasound bone densitometer for assessment of bone condition at lumbar vertebrae and femoral neck using proprietary R.E.M.S. technology. Available in portable and fixed configurations.
- EchoStation
- EchoS Plus
- EchoHybrid
- EchoHybrid Plus
- EchoStudio
Products and services
- EchoS Main bone densitometer using proprietary REMS technology. A radiation-free ultrasound device for assessing bone density and quality at lumbar vertebrae and femoral neck, providing BMD, T-Score, Z-Score, and Fragility Score; available in standard and portable versions.
- EchoS Plus Enhanced configuration of the EchoS bone densitometer with additional features targeted at hospitals, clinics, pharmacies, and home care settings.
- EchoStation Dedicated workstation configuration of the EchoS bone densitometer designed for hospitals and clinics requiring a fixed setup for bone density assessment.
- EchoHybrid Bone densitometry configuration pairing the EchoS main ultrasound unit with a cart and medical PC for clinical centers and remote locations requiring maximum versatility.
- EchoHybrid Plus Top-of-range bone densitometry configuration combining the main ultrasound unit, cart and medical PC, and a hard carrying case with integrated PC for maximum deployment versatility.
- EchoStudio Bone Density Software module for assessment of bone mineral density on lumbar vertebrae (L1-L4) and femoral neck, providing BMD (g/cm2), T-Score, and Z-Score for osteoporosis diagnosis.
- EchoStudio Body Composition Software module for analysis of body component distribution, providing BMI, percentage Fat Mass, and Basal Metabolic Rate measurement during ultrasound scan.
- EchoStudio Fragility Score Software module that evaluates internal bone structure quality and bone fragility through proprietary spectral analysis independent of BMD.
- EchoStudio Fracture Risk Software module providing 5-year fracture risk assessment on lumbar vertebrae and femoral neck by combining fragility information with BMD.
- EchoStudio Skeletal Software application for musculoskeletal ultrasound evaluations used with the linear probe for skeletal assessments.
- EchoStudio Gynecology Software application for gynecological ultrasound evaluations used with the endocavity probe.
- Convex Probe Convex ultrasound probe for abdominal ultrasound evaluations and wide-field imaging applications with the EchoS platform.
- Linear Probe 40mm linear probe matched with EchoStudio Skeletal software for musculoskeletal ultrasound evaluations.
- Endocavity Probe Endocavity ultrasound probe matched with EchoStudio Gynecology software for gynecological ultrasound evaluations.
Quantifiable outcome
- REMS and DXA show no statistical difference in FRAX fracture risk probabilities using femoral neck T-score, enabling equivalent clinical decision-making
- +2 more outcomes
Companies that use Echolight
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles5 records
Echolight technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature6 records
Echolight partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered flagship and core.
- NASAflagshipNASA uses Echolight's proprietary REMS technology to monitor bone changes in human bedrest studies and assess effects of unloading on bone mass during spaceflight simulations. The portable device (size of small suitcase) enables fast scan times under 10 minutes with edge analytics and ability to scan frequently without radiation. Prof. Aenor Sawyer (UCSF Space Health) highlighted the strategic importance for longer missions to Moon and Mars where real-time bone loss monitoring becomes critical.
- Aurora Spine CorporationcoreCo-marketing partnership between Echolight Medical and Aurora Spine Corporation. Both companies operate in the spine and bone health space, with Aurora Spine focused on spinal surgery solutions and Echolight providing bone density assessment. The partnership enables cross-promotion to shared healthcare provider audiences.
- Italian National Research Council (CNR)flagshipEcholight originated as a spin-off from CNR. The company maintains ongoing collaboration with CNR researchers for clinical studies and R&D activities. First multi-center clinical validation study for REMS technology was conducted in collaboration with CNR at major osteoporosis reference centers worldwide.
Scale indicators7 records
Recent moves8 records
Expansion highlights6 records
Echolight competitors and assessment
Company assessmentDirect peers
- GE Healthcare: GE Healthcare's Lunar iDXA and Prodigy bone densitometers are the other dominant DXA franchise globally. Echolight's REMS targets the same clinical use case (lumbar spine + femoral neck BMD) with an ultrasound-based, non-ionizing approach.
- Hologic: Hologic's Horizon and Discovery DXA systems are the leading bone densitometry devices in hospitals and women's health centers. Echolight competes head-to-head with Hologic's installed base by offering a radiation-free alternative for osteoporosis diagnosis.
- OsteoSys: OsteoSys (South Korea) manufactures quantitative ultrasound (QUS) bone densitometers such as the Sonost series, targeting the same osteoporosis screening segment as Echolight EchoS. Direct ultrasound-bone-densitometry competitor in the portable and primary-care channel.
- Mindways: Mindways provides quantitative CT (QCT) and DXA software for volumetric and trabecular bone density assessment. Competes in the bone densitometry analytics and software layer adjacent to Echolight's EchoStudio software modules.
- Norland (Swissray/Swissmed): Norland has historically supplied DXA bone densitometry systems for clinical and research use. Competes in the same hospital/research bone densitometry market that Echolight addresses via REMS technology.
Emerging players
- CompuMed: CompuMed provides bone densitometry analysis software and telereading services, including OsteoGram and iNSTech platforms. Comparable as a software/analytics player serving osteoporosis screening workflows.
- BeamMed (Sunlight Medical): BeamMed markets Sunlight Omnisense quantitative ultrasound bone densitometers at peripheral skeletal sites. Direct technology competitor in ultrasound-based bone assessment, though focused on peripheral rather than axial sites.
- Medimaps Group: Medimaps' TBS iNsight software adds Trabecular Bone Score analysis on top of DXA scans, addressing bone microarchitecture quality — the same clinical need that Echolight's Fragility Score targets. Comparable as a software-plus-imaging player in bone quality assessment.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Echolight social profiles
Digital presenceEcholight compliance and trust
Trust signalCompliance4 records
Echolight financial estimates
Financial estimateRevenue estimate
Valuation estimate
Echolight leadership team
Management profileNumber of profiles
Profiles2 records
Echolight subsidiaries and ownership
Company hierarchySubsidiaries1 record
Echolight funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Echolight M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Echolight
What does Echolight do?
Echolight manufactures and sells the EchoS family of ultrasound bone densitometers that use proprietary REMS (Radiofrequency Echographic Multi Spectrometry) technology to assess bone mineral density and microarchitectural quality at the lumbar vertebrae and proximal femur without ionizing radiation. The offering includes multiple hardware configurations (portable and workstation variants) for hospitals, clinics, pharmacies, home care, and wellness settings, paired with a suite of EchoStudio software modules covering bone density, body composition, fragility score, fracture risk, skeletal, and gynecological assessments. Customers include medical facilities, retail pharmacies, wellness centers, and research organizations such as NASA.
Is Echolight a public or private company?
Echolight is a private company. It is classified as venture growth investor backed and is currently operating.
When was Echolight founded?
Echolight was founded in 2010. It employs 11 to 50 people.
Where is Echolight based?
Echolight is headquartered in Lecce, Italy, in the Europe region.
How does Echolight make money?
Two revenue lines are on record. Bone Densitometry Hardware Sales are the primary driver. The others are software Licenses.
Who are Echolight's main competitors?
Direct peers on record are GE Healthcare, Hologic, OsteoSys, Mindways and Norland (Swissray/Swissmed). Emerging players are CompuMed, BeamMed (Sunlight Medical) and Medimaps Group.
Does Echolight have an API?
No public API is recorded for Echolight.
What industry is Echolight in?
Echolight's product category is Bone Densitometry Equipment. Its primary akta.pro industry code is HLAHABAD, Ultrasound & Echography Systems. Its NAICS code is 334510 and its SIC code is 3845.